INTRODUCTION
Inflammatory bowel disease (IBD) comprising ulcerative colitis (UC), Crohn's disease (CD) and IBD-unclassified (IBD-U) is a chronic inflammatory disorder of the intestine. 1, 2 Most patients affected by IBD require lifelong medical follow-up and medical or surgical treatments. Modern management of IBD should be governed by joint decision making with well-informed patients. Disease education is therefore paramount for effective treatment, which has been recognised by the British IBD standards. 3 Traditionally, patient education has been delivered through face-to-face encounters with clinicians, official patient information leaflets and meetings of patient support organisations. The advent of the Internet has opened new avenues for directed and self-directed patient education. Information on the Internet is provided through a variety of websites run by healthcare organisations, patient support organisations, pharmaceutical companies, news organisations and alternative health providers, as well as individuals contributing to patient experience blogs and discussion forums. 4 The information available on the Internet is of variable quality 4 and a systematic review found that in 2007, many websites were of poor quality. 5 Although most websites provide adequate information, 6 unsurprisingly, the quality of information provided by alternative health websites may be inferior to that from websites run by health care or patient support organisations. 4 Furthermore, the use of patient-friendly language could be increased to improve the poor readability of some websites. 4, 6 Efforts to promote the websites with best quality content are hindered by the fact that these websites often do not feature in the top three for the most commonly used Internet search engines. 7 Patients with IBD are increasingly using the Internet to search for information about their condition, as demonstrated by studies in North America 8 and the UK. 9 In both cohorts, more than half of the surveyed patients reported using the Internet for health-related issues. Younger patients and those with higher educational achievements were more likely to search for IBDrelated information. 8 While good quality information sources may improve disease-related patient knowledge, it is also conceivable that some (especially unregulated) information available on the Internet may cause anxiety. The hypothesis that the use of different information sources is associated with better patient knowledge and/or worse anxiety levels has so far not been rigorously investigated. The aim of this study was therefore to quantify the use of different information sources in a cohort of ambulatory patients with IBD, and examine any potential associations with patient knowledge (primary outcome) and anxiety.
MATERIALS AND METHODS

Study cohort and participant identification
Care for patients with IBD is almost exclusively provided by National Health Service hospitals in the UK. The ambulatory IBD clinics at Leeds Teaching Hospitals Trust provide secondary care for the population of Leeds (800 000 inhabitants) and tertiary referral care for patients from the surrounding areas. The total clinic cohort consists of approximately 3000 patients with IBD, of which the vast majority are secondary care patients. A total of 774 ambulatory patients with IBD were previously recruited to a cross-sectional observational study conducted at an initial clinic visit. Clinical data were collected at this point. This study was published elsewhere and received approval from the local research ethics committee in November 2012. 10, 11 These participants were sent a single postal invitation to provide additional data via a paper-based questionnaire for this current study.
Inclusion and exclusion criteria
The study recruited adult individuals with UC or Crohn's disease attending the IBD clinics at our hospitals. Patients were excluded from participation if they did not understand English (self-administered questionnaires), were suffering from IBD-unclassified (no accepted disease activity index) or, had a stoma (inability to calculate the Harvey-Bradshaw index).
Collected data
Demographic data included age, sex, ethnicity, marital status, educational level and tobacco and alcohol use. Type of IBD, disease duration and clinical phenotype were recorded using the Montreal classification. 12 Current and previous medical and surgical treatments were recorded, and current clinical disease activity was assessed with the simple clinical colitis activity index (for UC patients) 13 and the Harvey-Bradshaw index (for Crohn's disease patients).
14 Anxiety was assessed using the anxiety subscale of the hospital anxiety and depression scale (HADS-A) 15 at the time of disease activity assessment. Laboratory investigations included CRP and faecal calprotectin.
Additional data collection included disease-related patient knowledge, as assessed by the validated 24-point Crohn's and colitis knowledge score (CCKnow). 16 Participants reported access to the Internet, and frequency of accessing the Internet generally, and for health-related issues.
The investigators compiled a list of patient information sources on IBD using the existing literature 4, 6 and local patient feedback from an IBD patient panel consisting of expert IBD patients, who regularly advise on service matters and research plans. On the advice of the panel, more specific website examples were added to a list already compiled from the existing literature. The study questionnaire assessed the frequency of use for traditional information sources (general practitioner, hospital IBD team, patient information leaflets (in Leeds leaflets from Crohn's and Colitis UK are used exclusively), local patient organisation meetings), professional Internet websites (official websites by patient charity organisations and the National Health Service, news websites, patient-centred pharmaceutical support websites) and unregulated websites [patient discussion forums, alternative health provider websites (homoeopathy, nutritionists, etc.), random links after web searches]. Random links were defined as links appearing on search engines that did not belonging to any of the other categories of interest. For each category of information source, we provided several explanatory examples to guide participants (Table S1 ). Participants rated frequency of use ('I use this service for finding information on IBD') and trust in the source ('I trust the information provided by this service') separately using 5-point Likert scales (always, often, sometimes, rarely, never). Frequent use was defined as at least sometimes.
Sample size calculation
Calculations were made to determine power to answer the primary study hypothesis that patients using official information sources have higher knowledge than those relying on other sources. On the basis of Eaden et al., we assumed that official information source users will have a mean CCKnow score of 12.
16 Sample size calculations were based on the use of a twotailed t-test for the primary outcome. A sample size of 250 patients would give a 95% power to detect a difference of 1.25 in CCKnow (s.d. 5.5, 5% significance level). We anticipated a response rate of 33%, and hence sent the study questionnaire to all 774 patients.
Analysis plan
Data were first presented descriptively. Factors (disease characteristics, demographics, educational status, medical treatments and use of different information sources) potentially associated with HADS-A and CCKnow (continuous variables) were assessed were assessed by student t-tests and one-way ANOVA. Statistical significance was set at 5% and any significant variables were entered in multiple linear regression analysis. The analysis was performed with SPSS version 22 (SPSS Inc., Chicago, IL, USA).
Ethical approval and consent
The research protocol of this study was approved by the National Research Ethics Service Committee LondonHampstead (13/LO/1364). Return of the study questionnaire was taken as informed consent.
RESULTS
Study cohort
The study questionnaire was completed by 307 patients (response rate 39.7%). Of these, 188 (60.6%) were female and the mean age was 47.3 years (range 17-88 years, Responders to this study did not differ from the full study cohort, apart from a lower exposure to anti-TNF in this study cohort. The mean HADS-A score was 7.1 (range 0-21) with 67 (21.8%) participants classed as having borderline anxiety levels (HADS-A 8-10) and 68 (22.1%) participants classed as having abnormal anxiety levels (HADS-A > 10). The mean CCKnow score was 11.14 (range 0-24). There was no correlation between patient knowledge (CCKnow) and HADS-A (pearson correlation 0.008; P = 0.89). Patient organisation membership (Crohn's and Colitis UK) was relatively high with 22.3% indicating current membership and 18% previous membership. A total of 275 patients (89.6%) reported access to the Internet and 79.2% used the Internet at least daily.
Internet use for health-related issues was reported by 74.4%, with 27.7% indicating at least weekly use for health-related purposes.
Use of, and trust in, information sources Frequent use of information sources by participants included the hospital IBD team (82.3%), official patient information leaflets (59.5%) and official patient information websites (53.5%) ( Table 2 ). General practitioners (33.1%), patient forums (29.9%) and news websites (27.4%) were less frequently used, while Crohn's and Colitis UK meetings (3.3%), pharmaceutical websites (7.9%), alternative health websites (9%) and random links (17.3%) had the lowest rates of use.
Participants frequently trusted the information provided by the hospital IBD team (92.7%), official patient information leaflets (79.6%), official patient information websites (70.6%) and general practitioners (64.7%). Trust in information provided by news websites (39.7%), patient information forums (34.8%), random links (20.4%), pharmaceutical websites (17%), Crohn's and Colitis UK meetings (12.9%), alternative health websites (11.8%) was generally lower.
Variables associated with disease-related knowledge Younger patients had better disease-related knowledge (<60 years mean 11.7 vs. ≥60 years 9.5; P = 0.001), but no associations between sex, marital status, ethnicity, or tobacco or alcohol consumption and CCKnow scores were found (Table 3 ). Participants with university degree level education had better disease-related knowledge than those without (13.5 vs. 10.1; P < 0.001). A diagnosis of CD was associated with higher CCKnow scores than a diagnosis of UC (11.9 vs. 10.2; P = 0.005). Mean knowledge score was lower among mesalazine users (users 10.3 vs. non-users 12; P = 0.004), while patients using immunomodulators had better CCKnow scores than non-users (users 12.5 vs. non-users 10.3; P < 0.001). Patients with clinically active disease according to Harvey-Bradshaw Index or simple clinical colitis activity index had better disease-related knowledge than those in clinical remission (remission 10.6 vs. active disease 12; P = 0.016). There were no differences in disease-related knowledge between patients with normal and abnormal faecal calprotectin levels (Table 3) , even when three different thresholds (<50, <100, <250) were applied. Participants with current or past Crohn's and Colitis UK membership were more knowledgeable than nonmembers (13 vs. 9.9; P < 0.001). Daily Internet use (11.8 vs. less frequent 8.6; P < 0.001) and at least weekly Internet use for health issues were related with better diseaserelated knowledge (12.8 vs. less frequent 10.5; P = 0.001).
With the exception of attending the general practitioners and Crohn's and Colitis UK local meetings, the use of all other information sources was associated with higher CCKnow scores (Table 3; Figure 1 ). Multiple linear regression analysis (Figure 1) revealed that university degree level education (P < 0.001), use of immunosuppressants (P = 0.025), Crohn's and Colitis UK membership (P = 0.001), frequent use of the hospital IBD team for information (P = 0.032), and frequent use of official patient information websites (P = 0.005) were independently associated with higher disease-related patient knowledge.
Variables associated with anxiety levels
Younger patients (<60 years HADS-A mean 7.7 vs. ≥60 years 5.3; P < 0.001) and female patients (7.7 vs. male 6.1; P = 0.002) exhibited higher levels of anxiety, but no associations between marital status, ethnicity, tobacco or alcohol consumption, highest educational achievement, disease type, membership of Crohn's and Colitis UK, or exposure to different medications and HADS-A scores were found (Table 4) . Patients with clinically active disease had higher anxiety levels than those in clinical remission (8.6 vs. 6.3; P < 0.001). There were no differences in HADS-A scores between patients with normal and abnormal faecal calprotectin levels, even when three different thresholds (<50, <100, <250) were applied (Table 4) . Daily Internet use (7.5 vs. less frequent 5.7; P = 0.004) and at least weekly Internet use for health issues were associated with higher anxiety levels (8.3 vs. less frequent 6.5; P = 0.004). There was no correlation between HADS-A and CCKnow.
With the exception of using the hospital IBD team, local Crohns and Colitis UK meetings and pharmaceutical websites as information sources, the frequent use of all other information sources was associated with higher levels of anxiety (Table 4; Figure 2 ). Multiple linear regression analysis (Figure 2 ) revealed that female sex (P = 0.004), clinically active disease (P < 0.001), frequent use of general practitioners for information (P = 0.014), frequent use of alternative health websites (P = 0.004) and frequent use of random links on search engines (P = 0.016) were independent predictors of higher anxiety levels.
DISCUSSION
Patient education is a cornerstone of comprehensive care for patients with IBD. 3 This is the first study to investigate whether the use different information sources is associated with disease-related patient knowledge or anxiety. In this large cohort, we have demonstrated that ambulatory patients use their hospital IBD team and official patient information leaflets most often to gather information on IBD. Patients also trust these two sources the most. Patient education therefore should still include face-to-face education during routine clinical encounters and the use of printed information material. Official web-based information sources provided by healthcare organisation and patient support organisation were also frequently used and trusted. Other web-based information sources were used less frequently and fewer patients trusted them. It appears that many patients display a healthy level of scepticism when assessing nonregulated information on the Internet. We chose to report levels of trust for the whole cohort, rather than for just for participants who were regular users of specific information sources, as a perceived low level of trust may explain why some information sources were only used by a small minority of participants. We asked patients about random links as this might reflect noncritical information gathering type behaviour.
Disease-related patient knowledge was associated with a number of factors. More educated patients had better disease-related knowledge and, in line with previous studies, we have demonstrated that membership of a patient organisation is associated with better knowledge. 17 The severity and course of IBD may also influence patient knowledge, as we found that exposure to immunomodulators was independently associated with better knowledge. It is likely that the disease education, provided through membership and counselling for immunomodulator use, positively influences knowledge. The frequent use of nearly all information sources was associated with better knowledge on univariate analysis, but after multiple linear regression analysis only the association with frequent use of the hospital IBD team and official websites remained significant. In the light of this, patient education efforts should focus on face-toface education by gastroenterologists and IBD nurses, as well as signposting to official websites providing high quality patient information.
Anxiety levels were higher in women and those patients with active disease. There is a clear interplay with disease activity and anxiety levels, 18 which can be explained both by the direct effects of symptoms on the patients psychological status, as well as the interplay between abnormal pathophysiology and pathopsychology. Psychological stress may be implicated in the development of intestinal inflammation through proinflammatory cytokines. 19 A number of information sources were associated with worse levels of anxiety, including the use of general practitioners, alternative health websites and random unchecked links generated by search engines. Within the constraint of a cross-sectional study, and without the option of longitudinal assessments, we cannot draw any firm conclusions on causality here. It is conceivable the information provided by these sources induces anxiety. However, anxious patients may also seek out information from a wider variety of sources than patients without anxiety. Even in the absence of a clear causal link, patients should be advised to treat alternative information sources with caution. The study did not ask participants to rate the content of alternative health websites they accessed, nor would such data be of much value without in-depth reporting of specific individual websites (unlikely to be reported accurately). As such, we have no means to assess the quality of content.
We feel strongly that patients should be advised to apply caution when accessing alternative health websites, as the quality of content is often unknown. Patients may be at risk of increased anxiety, but they may also follow nonevidence based treatment advice and as such put their physical health in jeopardy.
Whether the frequent use of general practitioners relates to more frequent need for reassurance for some patients and therefore is a consequence, rather than the source, of anxiety also remains unclear. In contrast to a previous study, we did not find a correlation between knowledge and anxiety in this cohort. 17 Our data suggest that patients' experience of their disease, and specifically their experience of current symptoms, is significantly associated with knowledge and anxiety. Patients with clinically active disease had better disease-related knowledge (on univariate analysis only) and exhibited higher levels of anxiety. Interestingly, the objective level of intestinal inflammation, as measured by calprotectin, was neither associated with knowledge nor with anxiety. It appears that symptoms rather than inflammation are the main driver of anxiety, and that information gathering is also associated with active symptoms. Our findings are supported by evidence that perceived stress is also associated with symptoms but not with levels of intestinal inflammation. 10, 20 Membership of a patient support organisation was associated with significantly better knowledge, as also demonstrated consistently in previous studies. 17, 21 Very few patients, however, used local patient support organisation meetings for information gathering. In the light of this, efforts to provide patient education to a wider audience should focus on different formats, as the impact of education delivered through local patient support organisation meetings may be limited. The efforts by the pharmaceutical industry to provide patient education and support through web-based formats have so far (at least in our sample) failed to reach a significant number of patients. Furthermore, patients exhibited a low level of trust in information provided by the pharmaceutical industry, which may relate to healthy scepticism rather than the highly regulated and scrutinised content of the websites. It is therefore questionable whether efforts by the pharmaceutical industry are likely to achieve the objectives of patient education and support.
There are a number of limitations to this study. First, the study cohort comprised patients from a single institution in the UK, and the results may therefore not necessarily be representative of other centres and/or countries. Ideally, the study would have involved a true population-based cohort. The study cohort consisted predominantly of secondary care patients and the disease characteristics of our cohort (high remission rates, relatively low use of immunomodulators and biologics) make it unlikely that significant selection bias towards a highly specialised referral cohort has occurred. Our rate of patients exposed to anti-TNF therapy was comparatively low. There are a number of explanations for this: In the UK, at the time this study commenced, anti-TNF therapies were only approved for use in UC as rescue therapy for acute severe UC. The National Institute for Health and Care Excellence (NICE) has only recently endorsed their use for chronic relapsing and remitting UC. Our centre provides care for approximately 1500 patients with CD, of whom 500 have received anti-TNF since 2000. The proportion of patients with Crohn's disease receiving these therapies in this study is a little lower than in other cohorts and may reflect slightly milder disease. This study consisted of mainly White Caucasian patients, who are representative of our local population. There are, however, significant differences in patient knowledge between ethnicities and countries. 22 Second, the study assessed knowledge and anxiety at a single time point, rather than studying trends over time. While it would be desirable to examine the development of knowledge and anxiety in an inception cohort, this would require a much larger multi-centre approach, with significant financial resources. This study examined traditional and web-based information sources. Patients with IBD also frequent social media and a number of studies have looked at the available information and the use of social media. 7, [23] [24] [25] We did not specifically examine the use of social media, such as Facebook, Twitter, Youtube or Instagram in this study. However, the social media strategy of the patient support organisation Crohn's and Colitis UK is based on the principle of creating awareness with links to their website for further information. The study should therefore adequately cover this use indirectly. Furthermore, we did not ask patients about healthcare utilisation, the frequency of contact with the IBD team or which members of the hospital IBD team they most often approached for information and can therefore not comment on whether different professional background (physician, nurse, dietician, pharmacist) or seniority influence patient knowledge or satisfaction. Data elicited by CCKnow and HADS scores are often not normally distributed, and we also found this to be the case for this study. We chose to analyse the data using t-test and linear regression analysis, as the statistical literature suggests that the use of parametric tests, rather than nonparametric tests, delivers the same results provided the sample size is as large as in our study. 26 On the basis of the findings of this study, we recommend the continued use of face-to-face education by IBD doctors and nurses, as well as written patient information material as first-line patient education. The difficulties of delivering face-to-face education in a busy clinic environment could be overcome by setting up dedicated patient education programs, which have been shown to be successful. 27 Patients should be guided towards official patient information websites from healthcare organisations and patient support organisations. We did not find any evidence that unregulated websites discussing patient experiences, such as blogs or forums led to significant anxiety, but patients should be warned about the link between anxiety and the use of alternative health websites or random links from search engines.
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